Correlation Between IShares Global and ARK Genomic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Global and ARK Genomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Global and ARK Genomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Global Healthcare and ARK Genomic Revolution, you can compare the effects of market volatilities on IShares Global and ARK Genomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Global with a short position of ARK Genomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Global and ARK Genomic.

Diversification Opportunities for IShares Global and ARK Genomic

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between IShares and ARK is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding iShares Global Healthcare and ARK Genomic Revolution in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ARK Genomic Revolution and IShares Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Global Healthcare are associated (or correlated) with ARK Genomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ARK Genomic Revolution has no effect on the direction of IShares Global i.e., IShares Global and ARK Genomic go up and down completely randomly.

Pair Corralation between IShares Global and ARK Genomic

Considering the 90-day investment horizon iShares Global Healthcare is expected to under-perform the ARK Genomic. But the etf apears to be less risky and, when comparing its historical volatility, iShares Global Healthcare is 3.96 times less risky than ARK Genomic. The etf trades about -0.31 of its potential returns per unit of risk. The ARK Genomic Revolution is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  2,406  in ARK Genomic Revolution on August 27, 2024 and sell it today you would lose (23.00) from holding ARK Genomic Revolution or give up 0.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

iShares Global Healthcare  vs.  ARK Genomic Revolution

 Performance 
       Timeline  
iShares Global Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Global Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest fragile performance, the Etf's basic indicators remain steady and the new chaos on Wall Street may also be a sign of medium-term gains for the ETF firm stakeholders.
ARK Genomic Revolution 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ARK Genomic Revolution has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Etf's forward-looking signals remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the Exchange Traded Fund stockholders.

IShares Global and ARK Genomic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Global and ARK Genomic

The main advantage of trading using opposite IShares Global and ARK Genomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Global position performs unexpectedly, ARK Genomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARK Genomic will offset losses from the drop in ARK Genomic's long position.
The idea behind iShares Global Healthcare and ARK Genomic Revolution pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities